Softgel Source, LLC (SGS) announced today its 2026 program for rapid turnaround of low volume, custom ingestible softgels, offering production priority and no minimum order quantity (MOQ) to facilitate quick product testing. The program, based in Portland, Oregon, aims to support U.S. biotech and pharmaceutical businesses in developing and testing new softgel products and formulations, enhancing their competitive edge.
“U.S. companies are at a crossroads, facing both the challenge and opportunity of bringing manufacturing back home,” said Kevin McDowell, Founder and CEO of Softgel Source, LLC. “By having our headquarters in Portland, Oregon USA, we’re well-positioned to help U.S. biotech and pharmaceutical businesses rapidly develop and test new and improved softgel products and formulations, creating a stronger competitive edge in their product marketplace.”
The expansion reflects a nationwide surge in U.S. manufacturing. According to a study from Deloitte and The Manufacturing Institute, U.S. manufacturing job growth is expected to continue, requiring millions of new workers. Biotech and pharmaceutical manufacturing are projected to grow 6–8% annually through 2030.
Businesses reliant on offshore manufacturing face challenges such as disrupted supply chains, long lead times, and shifting tariffs. SGS’s domestic operations offer shorter supply chains and more responsive manufacturing. “Located in the Pacific Northwest, SGS is ideally positioned to help companies address these offshore manufacturing issues,” McDowell said. “We help companies rapidly test, scale and adapt by offering U.S.-manufactured softgels that meet the highest standards of quality and compliance at fast turnaround rates. From biotech labs to innovative nutritional supplements, the company delivers solutions that enable efficiency, consistency, and growth. We’re also an excellent choice for backup production when offshore sources falter.”
Constant regulatory changes also drive demand for rapid prototyping. Many products require reformulation and retesting to comply with new regulations, often on short notice. “Continuous changes in U.S. and international regulations mean that many companies with softgel products affected by those changes need a way to rapidly test new products and formulations and get updated products into production fast,” added McDowell. “A local U.S. based manufacturer like SGS with fast turnaround and low MOQ is ideal for companies dealing with those types of time sensitive reformulation and testing requirements.”
Softgel Source is a boutique manufacturer of custom ingestible softgels for the vitamin, medication, supplement, and pet product industries. Located in Portland, Oregon, SGS focuses on high touch custom softgel manufacturing for U.S. based clients, emphasizing responsive, rapid turnaround of prototype production and low-to-moderate volume manufacturing. More information is available at https://softgelsource.com.
